Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 17.32B | 17.60B | 17.47B | 16.95B | 13.26B | 13.14B |
Gross Profit | 1.89B | 2.22B | 1.48B | 2.29B | 2.34B | 3.39B |
EBITDA | 3.35B | 3.69B | 2.91B | 3.82B | 2.97B | 4.21B |
Net Income | 580.00M | 706.00M | 281.00M | 824.00M | 893.00M | 1.67B |
Balance Sheet | ||||||
Total Assets | 44.61B | 44.58B | 45.26B | 45.72B | 47.24B | 45.60B |
Cash, Cash Equivalents and Short-Term Investments | 5.99B | 5.76B | 5.57B | 4.37B | 4.53B | 5.27B |
Total Debt | 22.56B | 22.03B | 23.88B | 24.36B | 26.47B | 25.42B |
Total Liabilities | 26.10B | 25.89B | 27.03B | 27.53B | 29.70B | 28.68B |
Stockholders Equity | 18.51B | 18.68B | 18.23B | 18.19B | 17.54B | 16.92B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.29B | 1.93B | 2.14B | -1.36B | -2.07B |
Operating Cash Flow | 0.00 | 2.98B | 2.58B | 3.67B | 2.77B | 4.08B |
Investing Cash Flow | 0.00 | -682.00M | -630.00M | -1.54B | -4.25B | -6.12B |
Financing Cash Flow | 0.00 | -2.11B | -745.00M | -2.29B | 708.00M | 3.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥9.45B | 13.14 | 1.86% | 0.72% | 153.87% | ||
66 Neutral | $17.06B | 17.77 | 5.60% | 3.68% | 6.63% | 11.55% | |
― | $551.48M | 14.35 | 3.54% | ― | ― | ― | |
72 Outperform | ¥77.97B | 15.42 | 3.39% | -9.53% | -10.29% | ||
55 Neutral | ¥57.66B | 156.89 | 1.49% | -21.43% | ― | ||
54 Neutral | ¥26.34B | 129.28 | 2.07% | 19.71% | -82.80% | ||
29 Underperform | ¥15.00B | ― | ― | 47.60% | 25.72% |
EF-ON Inc. has reported its consolidated financial results for the six months ending December 31, 2024, under Japanese GAAP. The company experienced a slight decline in net sales by 1.1% compared to the previous year, yet saw significant growth in operating profit and ordinary profit by 30% and 58.1% respectively. This reflects a strategic improvement in operational efficiency. Despite the decrease in total assets, the equity ratio has improved slightly, indicating a healthier balance sheet. The forward-looking statements forecast a positive outlook for the full fiscal year ending June 30, 2025, with expected increases in net sales, operating profit, and earnings per share.